Indication: Specifically for vitamin B12 deficiency due to supplemental insufficiency, certain anemias, gastrointestinal malabsorption, and neurological conditions associated with low B12 levels
General browsing for related supplies is available through General Care Supplies
Some research indicates a potential risk for promoting tumor growth due to its potent angiogenic propertiesan essential factor warranting rigorous evaluation, especially for individuals with a history of cancer or those at high risk
10.1007/S11248-014-9802-3 9 BuffoneM
Conclusions Ultimately, the current maintenance dose of 1,000 mcg B12 every 3 months may confer long term harm, therefore it seems that once B12 levels are stabilised well within acceptable range, then the standard B12 intervention of 1000 mcg should be administered annually, and monitored with pre-injection annual testing of levels